Clinical trial

Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension

NCT03277651

Study summary

ClinicalTrials.gov

Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention hemodynamics tests Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2017-10-09

PhaseN/A

Conditions

Liver Fibrosisunresolved

Cirrhosisverified · MONDO: cirrhosis of liver

Portal Hypertensionverified · MONDO: portal hypertension

Interventions

hemodynamics testsDIAGNOSTIC_TEST

Sponsors & collaborators

Shanghai Zhongshan Hospitallead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03277651 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.